NCCN 2018 Nursing Program Webinar Series - Improving Quality of Care for Lesbian, Gay, Bisexual, and Transgender (LGBT) Patients

June 12, 2018

LGBT individuals may show an increased incidence of certain cancers, but are less likely to receive regular medical care and standard cancer screenings. This lack of adequate medical care may be partially due to stigma and discrimination in health care settings. By educating themselves on issues facing LGBT patients with cancer and ways to address those issues, nurses can develop strategies to create a welcoming and inclusive practice environment for their LGBT patients.

Target Audience

This educational program is designed to meet the educational needs of oncology nurses who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Describe how rates of cancer screening uptake, incidence, and treatment outcomes in the LGBT populations compare to the general population and what may account for differences between these groups.
  • Discuss common disparities LGBT individuals experience during their cancer care.
  • Identify strategies to improve the quality of cancer care provided to LGBT patients and to provide welcoming and inclusive practice environments.
Additional information
Supporters: 

Supported by educational grants from:

  • Celgene Corporation
  • Novartis
  • Pfizer

Supported by an independent educational grant from Incyte.
Supported by a medical education grant from Exelixis, Inc.
Supported by an unrestricted educational grant from Gilead Sciences, Medical Affairs

Course summary
Available credit: 
  • 1.00 ANCC contact hours
  • 1.00 Participation
Course opens: 
05/22/2018
Course expires: 
08/12/2018
Event starts: 
06/12/2018 - 12:00pm
Event ends: 
06/12/2018 - 1:00pm
Cost:
$0.00

David Rice, PhD, MSN, RN, NP, NEA-BC    
City of Hope

Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education (CE) activities are expected to disclose any relevant financial relationships with a commercial interest as defined by ACCME’s, ACPE’s and ANCC’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Definitions  
NCCN continuing education considers financial relationships to create a “conflict of interest” when an individual has both a financial relationship with a commercial interest and the opportunity to affect CE content about the products or services of a commercial interest with which he/she and/or a spouse or partner has a financial relationship.

NCCN continuing education considers “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.  NCCN does not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship.

Faculty Disclaimers  
All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery.

Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling.

Faculty Disclosures
The faculty listed below discloses no relevant financial relationships:
David Rice, PhD, MSN, RN, NP, NEA-BC

NCCN Staff Disclosures
The NCCN Activity Planning staff listed below discloses no relevant financial relationships:
Kimberly Bayer; Melissa Esplen; Mark A. Geisler; Kristina M. Gregory, RN, MSN, OCN; Kristin Kline Hasson; Rose Joyce; Karen Kanefield; Heather Matt; Joan S. McClure, MS; Diane McPherson; Melanie Moletzsky; Lisa Perfidio, MS; Liz Rieder; Shannon Ryan; Kathy Ann Smith, CMP, CHCP; Melinda Somasekhar, PhD (Employed by NCCN until 10/30/17)

The NCCN Activity Planning staff listed below discloses the following relevant financial relationships:
Donald Harting, ELS, CHCP
Laboratory Corporation of America (LabCorp): Equity interest/Stock Options

Katherine Pierce
Boston Scientific Corporation: Equity Interest/Stock Options
Pfizer Inc.: Equity Interest/Stock Options

The NCCN Clinical staff listed below discloses no relevant financial relationships:
Lisa Gurski, PhD

Nurses
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

NCCN designates this educational activity for a maximum of 1.0 contact hour.

Available Credit

  • 1.00 ANCC contact hours
  • 1.00 Participation

Accreditation Period

Course opens: 
05/22/2018
Course expires: 
08/12/2018

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need:

  • A device with an Internet connection and sound playback capability
    • One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
    • Internet Explorer is no longer supported
  • Adobe Reader or other PDF reader software for certificate viewing/printing